HCID 11446791, compound → HCID 131725822, compound
Reaction equation
[CH2:1]1[C@H:14]2[C@@H:5]([NH:6][C:7]3[C:12]([CH2:13]2)=[CH:11][CH:10]=[CH:9][CH:8]=3)[CH2:4][CH2:3][CH2:2]1.C1[C@@H]2[C@H:18]([NH:19]C3C=CC=CC=3C2)[CH2:17]C1>>[CH2:11]1[C@H:12]2[C@@H:7]([N:6]([CH2:17][C:18]#[N:19])[C:5]3[C:14]([CH2:13]2)=[CH:1][CH:2]=[CH:3][CH:4]=3)[CH2:8][CH2:9][CH2:10]1Participants
3
Procedure
The title compounds were prepared according to the procedure of Example 1 step 3 except that Cis and Trans-1,2,3,4,4a,9,9a,10-octahydroacridine were used instead of Cis and Trans 2,3,3a,4,9,9a-Hexahydro-1H-cyclopenta[b]quinoline, respectively.
Sources & evidence
- ORD record
- ord-bd9fb46e6114406580b1bd0760b0f37d
- Source dataset
- uspto-grants-2006_07
- Patent number
- US07071185B2
Reaction notes
Loading…